Study: Recovered COVID-19 patients likely have antibodies for at least 6 months


Researchers in the United Kingdom have found that most people who become infected with the coronavirus still have high levels of antibodies for at least six months after their recovery.
The study of 20,000 people was conducted by UK Biobank, with the results published on Wednesday. The scientists discovered that among subjects who previously tested positive for COVID-19, 99 percent had antibodies to SARS-CoV-2 three months after being infected, and after six months, 88 percent still had antibodies.
Naomi Allen, professor and chief scientist at UK Biobank, told reporters during a news conference that these numbers are consistent with findings from earlier studies carried out in the UK and Iceland. "Although we cannot be certain how this relates to immunity, the results suggest that people may be protected against subsequent infection for at least six months following natural infection," she said. "More prolonged follow-up will allow us to determine how long such protection is likely to last."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The study began last May, and UK Biobank found that the proportion of the population with COVID-19 antibodies rose from 6.6 percent at the start of the study to 8.8 percent by the end of the year.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Colleges are canceling affinity graduations amid DEI attacks but students are pressing on
In the Spotlight The commencement at Harvard University was in the news, but other colleges are also taking action
-
When did computer passwords become a thing?
The Explainer People have been racking their brains for good codes for longer than you might think
-
What to know before 'buying the dip'
the explainer Purchasing a stock once it has fallen in value can pay off — or cost you big
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows